Medical science has made rapid advancements in the recent times, especially since the intervention of technology. 3D cell culture is one such advancement in the medical science, which is used to illustrate the cellular structure in humans and in finding applications in therapeutic research. This is why the global 3D cell culture market is anticipated to reach over $2,768.8 million by 2026, reports Polaris Market Research.

If you are wondering what is 3D cell culture then let me explain that it is a cluster of biotic cells that are allowed to cultivate in artificial media in three dimensions. This type of cell culture is used in tissue engineering and drug discovery, due to its property of providing prognostic data for in vito tests and physiologically pertinent statistics. The 3D cell cultures have a longer lifespan as well as more stability when compared to 2D cell culture system. This property makes them appropriate for long-term studies and long-term effects of the drug on cells.

3D cell culture systems are mostly grown in 3D cell colonies or bioreactors. Research studies estimated that they function similar to natural cells due to which they have applications in oncology research. The report also mentions that rising occurrence of several types of cancer cases and the need for effective and affordable treatment are the major factor driving the growth of the 3d cell culture market. Even WHO in 2015 estimated that nearly 8.8 million deaths due to cancer globally. But the development of optimized 3D assays, growing investment in healthcare, rising R&D investments and other research associated activities enable propelling the growth of 3D cell culture market significantly.

Today, the 3D cell cultures are mostly used for testing efficacy of new drug development, which will further be used for the treatment of chronic diseases such as cancer, cardiovascular and neurological ailments. This growth implementation of the 3D cell culture by biotechnology and pharmaceutical industries, which in turn is driving the growth of 3D cell culture market. However, there are some latent hesitancy in the market and hence it does not appear to be developing at the predicted pace.

But still the 3D cell cultures will see considerable rise of use to mimic tissue-like structures, able to exhibit differentiated cellular function, can simulate microenvironment conditions and better predict in vivo responses to drug treatment. This is just the beginning and the way forward for the industry is filled with silver linings.